Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
- PMID: 8307044
- DOI: 10.1007/BF02098463
Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
Abstract
A complement fixation (CF) test, a micro-immunofluorescence (micro-IF) test and an enzyme immunoassay (EIA) using Re-lipopolysaccharide as antigen were compared in the diagnosis of chlamydial infection in 136 mainly elderly patients hospitalized with community-acquired pneumonia during a Chlamydia pneumoniae epidemic in Finland in 1986-1987. Chlamydial pneumonia was diagnosed in 58 (42.6%) of the 136 pneumonia patients; 44 (75.9%) of them could be shown by micro-IF to be caused by Chlamydia pneumoniae, three by Chlamydia psittaci and four by Chlamydia spp. Only 5 (11.4%) of 44 patients with Chlamydia pneumoniae pneumonia were IgM-positive, indicating that the majority of cases were reinfections. In this population of mainly elderly patients the CF test was insensitive, being positive in only 6 (10.3%) of 58 cases of chlamydial pneumonia. The EIA detected 72.4% of cases and micro-IF 87.9% of cases (including infections with Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia spp.). In the EIA 77% of positive cases were positive in serum samples taken a week apart, whereas the corresponding figure for micro-IF was 50%. In micro-IF the measurement of IgA antibody levels is recommended and IgM-positive sera should be retested after removal of IgG antibody to avoid false-positive findings due to presence of rheumatoid factor. The collection of a third serum sample, for instance one month after onset, is also recommended, since half of the patients showed a diagnostic response in the micro-IF only in the sera taken one month apart.
Similar articles
-
Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study.Scand J Infect Dis. 1999;31(3):255-9. doi: 10.1080/00365549950163536. Scand J Infect Dis. 1999. PMID: 10482053
-
Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae.Clin Diagn Lab Immunol. 2000 Sep;7(5):739-44. doi: 10.1128/CDLI.7.5.739-744.2000. Clin Diagn Lab Immunol. 2000. PMID: 10973447 Free PMC article.
-
Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults.J Med Microbiol. 1998 Jul;47(7):615-21. doi: 10.1099/00222615-47-7-615. J Med Microbiol. 1998. PMID: 9839566
-
[Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):409-19. Ann Biol Clin (Paris). 2006. PMID: 17040871 Review. French.
-
[Chlamydia pneumoniae: clinical, epidemiological and laboratory aspects].Rev Argent Microbiol. 1993 Apr-Jun;25(2):110-8. Rev Argent Microbiol. 1993. PMID: 8234732 Review. Spanish. No abstract available.
Cited by
-
Laboratory diagnosis of Chlamydia pneumoniae infections.Can J Infect Dis. 1995 Jul;6(4):198-203. doi: 10.1155/1995/696950. Can J Infect Dis. 1995. PMID: 22514397 Free PMC article.
-
Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.J Clin Microbiol. 1998 Aug;36(8):2301-7. doi: 10.1128/JCM.36.8.2301-2307.1998. J Clin Microbiol. 1998. PMID: 9666010 Free PMC article.
-
Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Clin Diagn Lab Immunol. 2005 May;12(5):654-9. doi: 10.1128/CDLI.12.5.654-659.2005. Clin Diagn Lab Immunol. 2005. PMID: 15879028 Free PMC article.
-
The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.J Clin Pathol. 1999 Feb;52(2):99-102. doi: 10.1136/jcp.52.2.99. J Clin Pathol. 1999. PMID: 10396235 Free PMC article. Clinical Trial.
-
Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice.Infect Immun. 2003 Sep;71(9):5156-62. doi: 10.1128/IAI.71.9.5156-5162.2003. Infect Immun. 2003. PMID: 12933859 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous